We kicked off April with Tamy’s first post on the PLab blog. She and Tom have been working hard to launch our Drosophila NGLY1 HTS campaign. Tamy describes an unexpected challenge we encountered during assay development.
DMSO and Drug Discovery https://t.co/DX9vn4lwqi
Fruit Flies and DMSO tolerance on our npc1 and ngly1— Tamy Portillo (@Tamy_Portillo) April 1, 2016
The second installment of the PERL101 story received shoutouts from nematode enthusiasts:
Nice worms–>mice validation story from @PerlsteinLab https://t.co/ca7UUsz4Ov
— Michael Hendricks (@MHendr1cks) April 11, 2016
Nice blog post from @PerlsteinLab on going from drug screening in C. elegans to testing leads in mice. https://t.co/MCA6q5X85Z @eperlste
— Jordan Ward (@Jordan_D_Ward) April 11, 2016
Phenomenal second act describing the path to a medicine: spoiler, nematodes rock for drug like properties @eperlste https://t.co/ZiGYJcqWOC
— Jeb Keiper (@JebKeiper) April 11, 2016
The first NGLY1 patient was diagnosed in East Asia. Ultra-rare diseases know no borders.
Wonderful day in Hong Kong w/ Tai Tai, 1st NGLY1 patient in East Asia. Now on to Japan for lots of meetings. pic.twitter.com/z1nDUTlWS9
— Grace Science (@gracescience) April 12, 2016
Two more workiversaries coming up soon (Sangeetha’s and Tamy’s)!
This month @NinaDiPrimio and @hartl_tom celebrate 2-year workiversaries!
— Perlara (@PerlaraPBC) April 15, 2016
We’ve migrated up 3rd Street from the Dogpatch Saloon to a new haunt. The pool table is just too tempting. And it’s much less noisy and crowded. We’ll revisit the Saloon more this summer.
.@PerlsteinLab happy hour at Sea Star. @letUbeU we are waiting for you @Snarik 🙂 pic.twitter.com/l8RMnyGXi7
— Nina DiPrimio (@NinaDiPrimio) April 30, 2016
Getting ready for @PerlsteinLab Happy Hour. Join us in Dog Patch.
— Happi Tom (@letUbeU) April 29, 2016
Since March we’ve raised $1.7M from new investors. It would not have been possible without YC.
Why Y Combinator? https://t.co/ivgBT4Tb5c
— Perlara (@PerlaraPBC) April 30, 2016
See you in June!
